Chris Coxon

Senior Lecturer in Medicinal Chemistry

University of Edinburgh


Dr Chris Coxon is Senior Lecturer in Medicinal Chemistry at the University of Edinburgh. His lab’s research is focussed on developing peptide-based chemical probes and medicines for neurological and neurodegenerative diseases – specifically migraine and Parkinson’s disease. His team has specific interest in peptide synthesis, modification (e.g. stapling and bioconjugation) DMPK evaluation and using fluorinated peptides to understand protein folding. He co-founded and is Director of Pepmotec Ltd – a bespoke peptide synthesis spin-out company. He is also a committee member of the Royal Society of Chemistry’s Protein & Peptide Science Group.